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Abstract

Chronic Obstructive Pulmonary Disease (COPD), a respiratory disease that leads to
reduced airflow, may result in difficulty swallowing with disease progression. The
coordination between the respiratory and swallowing systems decouple and they
may experience increased risk of aspiration. This study aimed to determine the
effects of lung volume on swallowing in individuals with COPD compared with older
healthy. Specifically, the study examined if altering lung volume at the time of the
swallow changed swallowing timing, specifically pharyngeal swallow duration, and
impacted the respiratory-swallow pattern in individuals with COPD. Measurement
of estimated lung volume (ELV), pharyngeal swallow duration, and respiratoryswallow patterning in individuals with COPD was compared with older healthy at
varying lung volume conditions. Participants completed seven 20 ml water bolus
swallows by medicinal cup across 4 lung volumes: non-cued volume (NC), and in
order of increasing volume, resting expiratory level (REL), tidal volume (TV), and
total lung capacity (TLC) . ELV was determined using respiratory inductive
plethysmography (RIP) and spirometry. Swallow timing was measured by events
during the swallow with pharyngeal manometry. Individuals with COPD had lower
lung volumes at the time of the swallow than older healthy individuals. A moderate
to strong negative relationship between estimated lung volume at the time of the
swallow and pharyngeal swallow duration was found in individuals with COPD that
was not present in the healthy participants. They had a longer pharyngeal duration
when swallowing at lower lung volumes. The percentage of swallows resuming on
vi

inspiration post-swallow were significantly greater in individuals with COPD than
the healthy. In the COPD group, resumption of respiration in inspiration occurred
significantly less often at the higher lung volumes (TLC and TV) than the lower
volume condition, REL. In conclusion lower lung volumes at the time of the swallow
in individuals with COPD were associated with longer pharyngeal swallow duration
and increased resumption of respiration in inspiration post-swallow.

vii
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Introduction
The American Thoracic Society (ATS), European Respiratory Society (ERS)
and Global Initiative for Chronic Obstructive Lung Disease (GOLD) define Chronic
Obstructive Pulmonary Disease (COPD) as a respiratory disease characterized by
reduced airflow that is not reversible by use of a bronchodilator or antiinflammatory therapies (Celli et al, 2004). COPD is preventable and treatable. The
World Health Organization predicts that COPD will be the third most prevalent
disease and rank fifth in level of disability by 2020 (O’Kane & Groher, 2009). The
National Heart, Lung, and Blood Institute estimated an annual cost of managing
COPD at $50 billion. COPD is the fourth leading cause of mortality in the United
States and Europe (Celli et al., 2004). Dysphagia, impairment in swallowing, is
present in 27% of individuals with COPD and the incidence of dysphagia increases
with COPD disease progression (McKinstry, Tranter, & Sweeney, 2010). Patients
with COPD demonstrate a discoordination between breathing and swallowing that
may be related to increased respiratory drive. Respiratory and swallowing
discoordination places patients at risk for penetration or aspiration, entrance of
food or liquid into the airway, and aspiration pneumonia (Coelho, 1987; Cvejic et al.,
2011). Further, adverse events such as increased hospitalizations and higher
mortality rates occur in individuals with COPD and dysphagia (Cvejic et al., 2011).
Historically, individuals with COPD were labeled with a range of obstructive
respiratory conditions such as emphysema or chronic bronchitis. Cross-agency
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efforts were instrumental in ensuring consistent, centralized diagnosis with the
umbrella term, COPD, to improve healthcare service delivery. Noxious particle or
gas exposure such as cigarette smoke, chemicals, or other toxins results in chronic,
abnormal inflammation of the lungs. In addition to inflammation reducing airflow,
emphysema impairs the elastic integrity of the alveolar sacs within the lungs
resulting in hyperinflation or air trapping (Celli et al., 2004; Hess, MacIntyre,
Mishoe, Galvin & Adams, 2012). Chronic bronchitis is indicated when an individual
has a productive cough lasting for three months or longer in two consecutive years
which cannot be explained by another condition (Celli et al., 2004). However, Hess
et al. (2012) cautions that individuals diagnosed with chronic bronchitis do not all
meet the irreversible airflow obstruction criteria for the COPD diagnosis. In the past,
individuals with repetitive airway inflammation presentation were labeled with
chronic bronchitis; however, in recent years, practitioners have been urged to
diagnose individuals with ‘airway disease’ (Hess et al, 2012). The preferred term,
airway disease, addresses the pulmonary changes evidenced in the central and
peripheral airway as opposed to the pulmonary changes only in the central airway
suggested by the chronic bronchitis definition (Hess et al., 2012). While cystic
fibrosis, bronchiolitis obliterans and bronchiectasis cause chronic limited airflow,
these conditions are not classified within COPD (Hess et al., 2012). Additionally,
individuals with asthma are rarely diagnosed with COPD (Mannino, 2002).
The gold standard for diagnosing COPD is spirometry, a “standardized and
reproducible test that objectively confirms the presence of airflow obstruction”
(Juvelekian & Stoller, 2010, p. 3). Spirometry is one component in pulmonary
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functioning testing (PFT). With calibration, spirometry is used to measure the
volume of air and rate of air movement (airflow) during an individual’s inhalation
and exhalation. The airflow and volume measurements are obtained by having the
individual breathe into a mouthpiece while in the sitting or standing position (Hess
et al., 2012). FEV1 is the amount of air an individual can forcefully exhale in one
second. Forced vital capacity (FVC) is the total air volume an individual exhales with
force after a large inspiration. Diagnostic testing with spirometry can measure
forced expiratory volume in one second (FEV1) divided by forced vital capacity
(FVC)1. A ratio of 0.7 documents the required airflow limitation to meet the COPD
diagnosis criteria (Celli et al., 2004).
COPD severity, determined via a classification scale such as the GOLD staging
system shown in Table 1, is based on the measured amount of lung function
impairment using spirometry (Mannino, 2002). The GOLD staging system is a 5stage scale (0-IV) ranging from ‘at risk’ (0) to ‘very severe’ (IV). In addition to the
use of the fixed FEV1/FVC ratio 0.7 confirming COPD diagnosis, the percent forced
expiratory volume in 1 second (FEV1%) is utilized to stage individuals with COPD
(Celli et al., 2004; Hess et al., 2012). The FEV1% is derived by comparing an
individual’s expiratory volume in one second to his/her peers of a similar age,
gender, height and mass. Celli et al. (2004) recognized limitations in singular use of
spirometry outcomes for severity staging and suggested stronger consideration of
body mass index (BMI) and dyspnea evaluation during exercise. However, the GOLD

1

FEV1/FVC is the amount of air that can be forcibly exhaled in one second divided the amount of air that
can be forcibly exhaled after taking as deep a breath as possible.
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severity staging scale, based on spirometry results, continues to be the most widely
accepted rating scale.
Table 1
GOLD COPD Severity Staging
Stage

Description

Findings: Postbronchodilator

0

At risk

FEV1/FVC  0.7

I

Mild

FEV1/FVC < 0.7; FEV180%

II

Moderate

FEV1/FVC < 0.7
FEV1 at 50 to 80%

III

Severe

FEV1/FVC < 0.7
FEV1 at 30% to 50%

IV

Very Severe

FEV1/FVC < 0.7
FEV1 at 30% or FEV150%
with severe chronic symptoms

Note. FEV1 ratios are based on a percentage of predicted normal value given age, gender,
height, mass and ethnicity.

Symptoms associated with COPD are dyspnea (shortness of breath) on
exertion, chronic cough, sputum expectoration and wheezing. Pursed-lip breathing
with prolonged expiration, barrel chest, accessory muscles usage during respiration
and cyanosis may also be present in individuals with COPD (Juvelekian & Stoller,
2010). Non-pulmonary complications may include: cardiovascular disease,
peripheral edema, cachexia (wasting syndrome), skeletal muscle dysfunction,
osteoporosis, and depression (Hess et al., 2012). Celli et al. (2004) identified COPD
risk factors to include:


Smoking



Socio-economic status



Occupation
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Environmental pollution



Perinatal events and childhood illness



Recurrent bronchopulmonary infections



Diet



Genetic predisposition



Gender



Airway hyperactivity and asthma

Exacerbation of COPD is defined as acute changes in: (1) dyspnea level, (2)
cough, and/or (3) sputum which require adjustments in regularly prescribed
medications (Celli, 2004). COPD exacerbations result in inflammation which may
cause irreversible disease severity progression (Hess et al., 2012). Medical
management for exacerbations may include: (1) a course of corticosteroids, (2)
antibiotic therapy, (3) oxygenation therapy adjustments to maintain  90% SpO2
while minimizing CO2 retention, and (4) intubation with ventilation (Hess et al.,
2012). Individuals with an exacerbation of COPD have demonstrated a statistically
significant higher respiration rate (24 breaths/minute) in comparison with healthy
elderly individuals (15.6 breaths/minute) (Shaker et al., 1992).
The cause of COPD exacerbations is still a point of debate in the medical
community although increased aspiration and penetration have been posited as a
trigger for an exacerbation onset (Gross et al., 2009; Terada et al., 2010). Abnormal
swallowing in COPD is associated with a significantly increased frequency of COPD
exacerbations per year than in individuals without swallowing impairment after
adjusting for other factors (Terada et al., 2010). Others posit that the respiratory
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decline during a COPD exacerbation, such as increased dyspnea and tachypnea,
further impair the respiratory-swallow coordination and result in greater
penetration and/or aspiration. This evidence suggests a relationship between
altered swallowing and increased frequency of COPD exacerbations.
Airway protection during a swallow requires a cessation of respiration, or
“swallow apnea”, ranging from .75-1.5 seconds while the bolus passes through the
pharynx followed by a resumption of respiration signaling the end of the swallow
(Klahn & Perlman, 1999; Martin-Harris, 2008; Perlman, He, Barkmeier & Leer,
2005). This suggests a central coordination between the respiratory and
swallowing central pattern generators (Broussard & Altschuler, 2000; Jean, 1984).
Young healthy individuals typically couple a swallow with the expiratory phase of
respiration (Cedborg et al., 2010; Martin-Harris et al., 2005; Martin-Harris, Brodsky,
Price, Michel, & Walters, 2003; Shaker et al., 1992; Wheeler Hegland, Huber, Pitts,
Sapienza, 2009). Specifically, they initiate the swallow and resume respiration after
the swallow during the expiratory phase (E-E pattern) of the respiratory cycle
(Martin-Harris et al., 2005). Resumption of respiration in the expiratory phase after
the swallow is posited to reduce aspiration risk. Deviations in the respiratoryswallow patterning occur in older healthy individuals resulting in more frequent
onset of the swallow during inhalation (I-E or I-I pattern) or respiratory resumption
in the inspiration cycle after the swallow (E-I or I-I pattern) than in younger healthy
persons (Shaker et al., 1992). Individuals with moderate to severe stable state COPD
have an altered respiratory-swallow patterning; specifically, they swallow solids in
inhalation and resume respiration on inhalation for semi-solid texture boluses
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(Gross, Atwood Jr., Ross, Olszewski, & Eichhorn, 2009). COPD patients in the
exacerbated state resume respiration post-deglutitively in the inspiratory phase
more frequently than healthy older peers (Shaker et al., 1992).
In addition to the reduction in respiratory-swallow pattern coordination,
individuals with COPD demonstrate: (1) diminished laryngeal elevation during the
swallow, (2) trending towards a lower laryngeal position at rest, (3) increased
pharyngeal transit duration, (4) fatigue of oral mastication with need for rest
breaks, (5) lingual peristalsis, (6) cricopharyngeal dysfunction and (7) a voluntary
prolongation of airway closure on certain bolus types (Coelho, 1987; Mokhlesi,
Logemann, Rademaker, Stangl, & Corbridge, 2002; Chaves et al., 2014). Pharyngeal
residue in individuals with stable COPD is not significantly different from their
healthy older peers (Chaves et al., 2014). Severe COPD individuals also demonstrate
severe cricopharyngeal dysfunction and particular difficulty with opening of the
upper esophageal segment for bolus passage into the esophagus. Some have
suggested that there is a correlation between cricopharyneal dysfunction and
gastroesophageal reflux (GER) (Stein, Williams, Grossman, Weinberg &
Zuckerbraun, 1990). Persons with severe COPD have a higher prevalence of GER
than healthy individuals. Further, GER was identified as a risk factor for
exacerbations (Sakae, Pizzichini, Teixeira, da Silva, Trevisol & Pizzichini, 2013).
Mechanisms driving respiratory-swallow coordination are largely unknown.
Central pattern coordination between respiration and swallowing involves neurons
in the ventrolateral medulla (Broussard & Altschuler, 2000; Davenport, 2011; Jean,
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1984). Sensory feedback to the respiratory and swallowing central systems prior to
swallowing is important for airway protection during swallowing (Table 2).
Increases in lung volume will activate pulmonary stretch receptors and increase
recoil forces in the chest wall (Gross, Steinhauer, Zajac, & Weissler, 2006; Gross et
al., 2012). Pulmonary stretch receptors provide peripheral feedback to the medulla
on lung volumes achieved before swallowing. Inadequate volumes are reported to
alter the coupling of respiration and swallowing and result in timing variances that
reduce airway safety (Gross et al., 2003).
Table 2
Lung Volume Sensory Feedback for Swallowing Coordination

Lung Volume
(Wheeler
Hegland et al.,

Swallowing
Target Involved
in Healthy
Subjects
43%-64% of Vital
Capacity

Feedback
mechanism
Pulmonary
stretch
receptors

Time of
Occurrence
relative to
swallow
Before the
swallow

Requirements
to Achieve
Target
Thoracic
expansion to
intake air

2009)

Given the bronchoconstriction and hyperinflation in COPD, lung volume is
posited as impaired in swallowing (Table 3). Decreased airflow within the smaller
airways, along with thoracic muscle wasting with disease progression and
hyperinflation, reduce lung volume in individuals with COPD (Gatta, Fredi,
Aliprandi, Pini, & Tantucci, 2013). Vital capacity measures of total lung volume were
reduced to 2.72 L (SD=.72) in COPD from the normal expected range of 3-5 L (Yuan
et al., 2014). Restricted thoracic expansion will lower inspiratory volumes limiting
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pulmonary stretch receptor input and reduce thoracic recoil. Further, a decrease in
expiratory airflow results in hyperinflation. An examination of the role of lung
volume on swallowing control in persons with COPD is needed.
Table 3
Proposed Mechanisms Affecting Swallowing Coordination in COPD

Respiratory Abnormality in COPD
Reduced Vital Capacity

Reduced Expiration Speed
Reduced Inspiration Volume

Mechanisms affecting Swallowing in COPD
Airway obstruction on Inspiration and
Expiration
Thoracic Muscle Wasting,
Decreased Recoil
Airflow obstruction
Decreased Mechanical Recoil during
Passive Expiration
Hyperinflation
Thoracic Muscle Wasting
Bronchoconstriction
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Proposal

This research project investigated the role of lung volume in the coordinated
coupling of breathing and swallowing in individuals with COPD when compared
with healthy individuals. The study examined how individuals with COPD swallow
at different lung volumes compared to older healthy individuals. In particular, the
effects of swallowing at different lung volumes on timing measures during
swallowing were investigated. Respiratory-swallow patterning in COPD is known to
vary from healthy individuals with more frequent resumption of respiration in the
inspiratory phase thus increasing the risk of aspiration. This study examined
whether swallowing at a higher lung volume changed timing of the pharyngeal
phase of swallowing and the pattern of resuming respiration on inspiration after the
swallow.
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Research Aim
Problem: Mechanism for dysphagia in COPD is not known.
Aim: Examination of the Relationship between Lung Volume and Swallowing
Control in COPD
The study contrasted varying lung volume during swallowing between individuals
with COPD and healthy participants. Further, the effects of lung volume
manipulation on temporal measures of swallowing such as pharyngeal duration
were determined. Respiratory-swallow patterning in COPD participants was also
compared across lung volume conditions.
Hypotheses:
1. Lung volumes for swallowing would be significantly lower in COPD than in
healthy participants.
2. Pharyngeal swallow duration will be related to lung volume at the time of the
swallow in COPD participants. Specifically, pharyngeal duration will decrease
when increasing lung volume in individuals with COPD.
3. Swallowing at higher lung volumes would result in less frequent resumption
of respiration during inspiration than lower lung volume conditions in
individuals with COPD.
Collectively, this research examined the effects of lung volume on swallowing in
individuals with COPD. It was determined whether lung volume abnormalities
related to difficulties in the coordination of breathing and swallowing in COPD. Also,
the effects of lung volume changes were examined on pharyngeal swallowing timing
in individuals with COPD.
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Significance
Individuals with COPD are at increased risk for swallowing impairment
resulting in aspiration and aspiration pneumonia (Terada, 2010). COPD patients
demonstrating an impaired swallowing reflex also have increased COPD
exacerbations (Terada, 2010). A respiratory decline is evidenced in COPD
exacerbations and patients frequently require hospitalization. Researchers
hypothesize that aspiration may be a risk factor for COPD exacerbations in addition
to risk of aspiration pneumonia. The lack of identification of the mechanisms driving
the COPD patient’s swallowing impairment is a critical barrier to determining
models to improve clinical outcomes in COPD. Further, investigation of the effects of
changes in lung volume is pivotal for developing appropriate treatment approaches.
This study will identify the mechanism driving the swallowing impairment and
determine if adaptations in volume can positively influence coordination between
the respiratory and swallowing systems. The study will have a broader impact by
providing a theoretical framework for additional clinical investigation studies aimed
at improving swallowing function in COPD and other respiratory compromised
populations such as lung cancer.
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Innovation
The effects of varying lung volume on swallowing in individuals with COPD
have not been investigated. Individuals with COPD exhibit progressive limitations in
airflow which are not completely reversible. We hypothesize that a limitation in
lung volume interferes with swallowing physiology and respiratory-swallow
coordination in COPD patients. Previous studies in healthy adults, found a reduction
in the lung volume amount at the time of the swallow resulted in alternations in
swallowing physiology such as delays in swallowing onset and increases in the
pharyngeal swallow duration (Gross, 2003). Our study will examine some of these
relationships in patients with COPD to better understand the mechanisms
underlying this disorder. Although others have documented swallowing deficits in
the COPD population, this research is the first aimed at establishing the
pathophysiology of swallowing in COPD. Without understanding the mechanisms
involved in swallowing difficulties in this disorder, treatment cannot be aimed at
improving the deficits in COPD. Increases in duration of the swallow could increase
the risk for aspiration in this respiratory compromised population. Mechanisms that
may improve the coupling of respiration and swallowing in COPD are not known.
Based on the first attempt to increase understanding of the pathophysiology of
swallowing in COPD to be provided by this investigation, investigations altering the
respiratory system by respiratory strength training could be relevant. Future
investigations could focus on altering respiration for prevention of aspiration by
using inspiratory and expiratory muscle strength training to change lung volume for
swallowing.
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Research Approach
1. Aim: Examination of the Relationship Between Lung Volume and Swallowing

Control in COPD
We determined: (1) lung volumes during swallowing in individuals with COPD in
comparison with healthy participants (2) the effects of manipulating lung volume at
time of swallow on swallowing physiology and (3) the effects of varying lung volume
on the respiratory-swallow patterning in COPD.
1.1

Background
Wheeler-Hegland et al. (2009) reported that healthy individuals (age range

19-28) swallow at 43-64% of vital capacity. Participants were observed to inspire or
expire to achieve the preferred lung volume (% VC) at the time of the swallow. The
vital capacity volume in individuals with COPD is reduced to 2.72 L (SD=.72) from
the normal expected range of 3-5 L (Yuan et al., 2014). The lung volume levels when
COPD individuals swallow is not known but is posited to be lower than healthy older
volunteers. Thus, individuals with COPD may need to swallow at a higher
percentage of their vital capacity to swallow safely.
One study found a reduction in lung volume at the time of swallow resulted
in delays in swallow onset and longer pharyngeal phase durations in healthy
participants (Gross, 2003). COPD patients had longer pharyngeal durations when
compared with healthy volunteers completing bolus swallows at their typical lung
volumes (Cassiani et al., 2015). Mokhlesi et al. (2002) noted prolonged airway
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closure for certain bolus types in 45% of COPD participants and suggested this was
a potential compensation mechanism to protect the airway.
A study examining the effects of swallowing at varying lung volumes in COPD
may identify mechanisms to help these patients swallow safely.
1.2 Purpose
Determine the effects of varying lung volume on swallowing control in COPD.
1.3 Hypotheses
1. Lung volumes for swallowing will be significantly lower in COPD than
in healthy participants.
2. Swallow duration will demonstrate a negative relationship with lung
volume in individuals with COPD. Specifically, individuals with COPD
will decrease their pharyngeal duration when swallowing at increased
lung volumes.
3. Swallowing at higher lung volumes will result in less frequent
resumption of respiration during inspiration than lower lung volume
in individuals with COPD.
1.4 Independent Variables


Participant group (Healthy or COPD)



Lung volume condition ( Table 4)

Table 4
Lung Volume Condition Definitions

Condition

Abbreviation Operational Definition

Non-Cued

NC

No instruction of when to swallow

Resting Expiratory Level

REL

Bottom of tidal breath

Tidal Volume

TV

Peak of tidal breath

Total Lung Capacity

TLC

Peak of deep breath
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1.5 Dependent Variables (Table 5)
Table 5
Dependent Variable Definitions and Measurement

Variable

Definition

Estimated

Estimated volume at

Lung Volume

time of the swallow

(L)

(Liters)

Method of Measurement


plethysmography (RIP)


Onset of BOT pressure

Swallow

increase to upper

Duration

esophageal sphincter

Interpolation using RIP and
spirometer

*%VC will be reported
Pharyngeal

Respiratory inductive



Time of BOT onset pressure
increase
o

sensor

(UES) negative pressure
offset

BOT manometer pressure



Time of offset of negative UES
pressure (at second peak in M
wave)
o

UES manometer pressure
sensor

Respiratory-

Expiratory-Expiratory

Swallow

(E-E)

Pattern

Expiratory-Inspiratory

Begin in expiration; resume in

(E-I)

inspiration

Inspiratory-Expiratory

Begin in inspiration; resume in

(I-E)

expiration

Inspiratory-Inspiratory

Begin and end swallow in inspiration phase

(I-I)

Begin and end swallow in expiration phase
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1.6 Methods
We studied the relationship between respiratory functioning and swallowing
functioning in persons with COPD when compared to healthy peers.
Participants
Healthy and COPD participants were 45 years of age or older to participate.
Inclusion criteria for COPD participants were: (a) a respiratory function screening
ratio result of 30% to < 70% (Ratio of forced expiratory volume in 1 second to
forced vital capacity via spirometry) (Celli et al., 2004), (b) COPD diagnosed by a
physician, (c) no exacerbation of COPD within last month, (d) no use of continuous
oxygen (O2) and (e) not diagnosed with bullous emphysema. COPD group
respiratory function screening ratio was M=51.67% (SD=8.31). The percent
predicted FEV1, determining COPD severity, ranged 34% to 80%. Applying the GOLD
COPD severity rating scale (Table 1), COPD participants’ severities were: one mild,
three moderate, and five severe COPD. One COPD participant was prescribed
supplemental oxygen at a rate of 2L O2 by nasal cannula at night and as needed
during exertional activities. This participant did not use oxygen during the study.
Healthy participants demonstrated a respiratory function screening ratio of 70%
FEV1/FVC for inclusion in the healthy group, M=82.2% (SD=7.4). Healthy
participants scored 8 or less (normal) on the Dysphagia Handicap Index (DHI)
which is a 100 point scale based on patient reports of swallowing difficulty
(Silbergleit, Schultz, Jacobson, Beardsley & Johnson, 2012). COPD participants

completed the DHI although no minimum or maximum scores were required for
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participation (see additional discussion of DHI in Other Screening Tools, p.31).
Three COPD participants exceeded the normal range on the DHI, 2 mild and 1
moderate. The moderate scoring participant was previously evaluated by a speechlanguage pathologist and diagnosed with dysphagia, but had not yet received
treatment. Healthy and COPD prospective participants also met a minimum score of
21 points on Mini Mental State Evaluation (MMSE) (21-24 points=mild, 25-30
points=normal cognition) (Folstein, Folstein & McHugh, 1975) and had a Reflux
Symptom Index (RSI) score <15. Additional exclusion criteria for COPD or healthy
participants were:


Direct dysphagia treatment within the last 3 months



History of brain injury or stroke



Diagnosed with progressive neurodegenerative disorders such as Parkinson’s
Disease, multiple sclerosis, peripheral neuropathy, and amyotrophic lateral
sclerosis



Previous neck injury requiring physician intervention



History of psychiatric disorder other than medically managed depression



Have a speech disorder with reduced ability to be understood by others



History of epileptic seizures



Inability to speak or understand English.
Healthy participants were recruited through James Madison University (JMU)

bulk emails and handouts or flyers at JMU. COPD volunteers were recruited through
Sentara Rockingham Memorial Hospital (SRMH) physician practices and related
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clinics such as pulmonology, cardiopulmonary rehabilitation clinic, or other
surrounding area healthcare providers within a one hour radius of the research site.
Community flyers and word of mouth recruitment methods were also employed in
recruitment of healthy and COPD volunteers. Telephone screens for inclusion
eligibility were conducted for each prospective participant. Informed consent and
the experimental study were conducted at the Voice and Swallowing Services clinic
in the Outpatient Treatment Center at Sentara RMH. Prospective participants
completed screening tasks for inclusion on the date of their scheduled visit after
completing informed consent. The study took 3 hours to complete including
informed consent, screening, and the experimental tasks. A copy of the signed
consent form was distributed to participants to take home.
Instruments
Instruments for measurement included: respiratory inductive
plethysmography, oral pressure, 3-sensor manometry, and spirometry. The
spirometer was utilized in the calibration tasks but was not used during the
experimental swallow tasks. Instruments used for identifying events included a
single axis accelerometer, synchronized video recording and a button-push pulse
generator.
Estimated lung volume was measured with respiratory inductive
plethysmography (RIP) (Respitrace®, Ambulatory Monitoring, Ardsley, NY) using
two elastic inductobands around the rib cage (RC) and abdominal (AB) cavities
measuring change in thoracic circumference in volts with synchronous spirometry.
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The Respitrace® recorded chest wall and abdominal movement. Although swallow
apnea, the period of respiratory cessation (respiratory offset to respiratory
resumption onset), has been reported in the literature as a method to determine
pharyngeal phase timing (Martin, Logemann, Shaker, Dodd, 1994), respiratory onset
or offset in the sum signal for RC and AB were not selected as temporal markers in
this study because liquid swallows by cup have shown variable apnea onset signals
(Martin-Harris, Brodsky, Price, Michel & Walters (2003). The RIP signal was used to
determine inclusion or exclusion of a trial in a lung volume condition based on lung
volume at time of swallow in real-time and off-line data analysis. Oral and
pharyngeal pressure signals were used instead to mark durations in swallowing.
Measurement of Respiratory Volume
The RC inductoband was positioned at the axilla with the connector pins
down and the AB band was placed below the last rib at the umbilicus with the
connector pins up. The signals from the AB and RC respiratory bands were input
into the oscillator module and RIP amplifier set on DC signal amplification with a 1:1
amplification for RC and AB signals. The RC, AB and Sum signals were input into a
16 channel PowerLab (ADInstruments, Dunedin, New Zealand). A sampling rate of
1K/s was applied in LabChart (ADInstruments, Dunedin, New Zealand) for signal
analysis. The bands were placed on the participant over tight fitting clothing for
accurate measurement of ribcage and abdomen movement. A mesh retainer was
positioned on the participant after placement of the inductobands to reduce
displacement during the study.
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A Universal Ventilation Meter (UVM) spirometer (Vacu-Med®, Ventura, CA)
was used during the calibration tasks. The bidirectional flow meter has a turbine
transducer. The inhalation and exhalation signals are combined into a sine-wave
signal by signal summation. Signal input into the PowerLab included the
inspiratory, expiratory and sum signals, each with a sampling rate of 1K/s. A new
filter mouthpiece was attached to the spirometer head prior to use for each
participant.
Measurement of Pharyngeal Pressure
A 3-sensor manometer, CTO-3(Gaeltec, Hackensack, NJ), was placed
transnasally into the pharynx to measure pressure changes during the swallow. The
flexible strain-gauge manometric probe was passed nasally and positioned in the
upper airway with pressure sensors inferiorly to superiorly as follows: (1) top of the
upper esophageal sphincter (UES) opening, (2) in the hypopharynx, and (3) at the
base of the tongue. The changes in pressure were used to mark temporal events
occurring in the sequence of the swallow. This study obtained two event markers
from the manometry signal: (1) the onset of increase in base of tongue pressure
served as the onset of the pharyngeal phase of the swallow and (2) the offset of
upper esophageal sphincter negative pressure signaled UES closure after the
swallow and the offset of the pharyngeal phase of the swallow (Figure 1).
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Figure 1. Manometer signal of swallow events in a non-cued 20 ml water bolus trial.

Placement of the Manometer
The manometer was placed in a warm water bath before insertion to
acclimate the catheter to body temperature versus room temperature. Prior to
manometer catheter insertion, participants were administered two puffs of Afrin
into each nostril. The lubricated catheter was inserted into the predetermined left
or right naris, passed over the soft palate and through the pharynx. The Gaeltec
CTO-3 diameter is 2.7 mm and 100 cm in length with numeric markings at 10 cm
increments to guide placement. Participants were instructed to swallow water
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boluses to assist with manometer entry into the upper esophageal sphincter (UES)
when directed by the speech-language pathologist. Accurate positioning of the
pressure transducer was determined by utilizing the pull-through placement
method (Witte, Huckabee, Doeltgen, Gumbley & Robb, 2008). The catheter was
swallowed into the upper esophagus with a typical reading of approximately 20 cm
at the nares. The catheter was correctly positioned when a M-wave pattern was
observed in the UES digitized data signal when asking the participant to swallow.
The pressure transducer was repositioned by incrementally retracting 1 cm on the
catheter until the peak-trough-peak signal was noted for the UES sensor signal and a
single pressure peak was observed for the base of tongue and hypopharyngeal
sensors in the LabChart signal. The manometry catheter was secured with Medipore
tape at the nares and forehead after a stable signal was maintained. A strain-relief
loop was adhered at the participant’s shoulder to prevent dislodging the catheter.
The Gaeltec CTO- 3 pressure transducer was connected to a quad bridge amplifier
(AD Instruments, Dunedin, New Zealand) with a Gaeltec connector, meeting
ADInstruments specifications. This connector allowed for 3 channel input to the
bridge amp and LabChart. A sampling rate of 10K for each channel was applied
during digitization.
A Glottal Enterprises (GE) PTL-1 oral pressure transducer and MS-110 data
amplifier (Glottal Enterprises, Syracuse, NY) transduced intraoral air pressure
changes during the swallow. The pressure transducer was connected to a 15 cm
length Tygon® tubing (Model R-3603, Saint Gobain, Valley Forge, PA) with an
adaptor, allowing insertion of an individually fit 3-4 cm length Tygon® tubing in the
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mouth. The inner tubing diameter was 3 mm, outer diameter was 5 mm and the wall
was 1 mm. The new, oral tubing was individually fit to rest on the anterior tongue
tip. The tubing was adhered to the cheek and the GE oral pressure transducer was
strain-relieved to the face (see Figure 4). The oral pressure transducer was input to
the GE MS-110® amplifier before entering the A-D converter, Power-Lab®. An
event comment was entered into the oral pressure channel signal off-line based on
the frame-by-frame synchronized video capture determination of bolus onset.
For each participant, a single axis piezoelectric accelerometer (Kistler
Instrument Co., Amherst, NY) taped with 3M transpore tape® to the skin and placed
midline on the neck between the thyroid notch and the bottom of the thyroid
cartilage was used to detect laryngeal elevation onset. The signal was input into the
Kistler Piezotron power supply coupler (Type 5118B2, Kistler, Amherst, NY). A gain
of 100 dB with a HP filter=.03 was applied at the power supply coupler. Off-line
data analysis was conducted using a 30 Hz high pass filter with signal rectification.
Digital video capture (Logitech mountable with USB connection) of the oral and
neck regions was temporally synchronized with the LabChart signal. Video
recording was at 30 frames/second.
Calibration
Respiratory Inductive Plethysmography Calibration into Liters
Prior to the participant’s arrival, both the RC and AB signals were zeroed by
pressing the Calibrate button and RC button to obtain a reading from the
Respitrace™ amplifier. If the reading was other than zero, then the RC zero knob was

25
adjusted until a 0 was shown on the digital display. This process was repeated for
the AB by leaving the Calibrate button pushed and depressing the AB button. The
sum button was depressed to ensure that the display still read zero and adjustments
completed as needed with the AB zero knob. The Respitrace™ amplifier gain for
both the RC and AB were set to 1. Calibrate and reference buttons were pressed
along with the RC. If the reading was other than 1, then the RC gain knob was
adjusted until the digital display reads 1. This process was repeated with AB after
pressing the AB button. Finally, the sum digital display read a gain of 2 to complete
the Respitrace™ instrument calibration.
Spirometer Calibration
The UVM spirometer was calibrated by delivering a known volume across a
known time to the spirometer head. The spirometer turbine was placed on the GE
calibrator unit (Glottal Enterprises, Syracuse, NY) using an adaptor and calibration
filter. The flow setting on the GE calibrator was set for 1 L/sec and 2 L volume.
Digitization in LabChart of the calibration flow cycle was initiated. Expiration and
inspiration values (in volts) were highlighted and entered into the DataPad in
LabChart for the second positive and zero segments. The 2 calibration points (in
volts) for the known 1 L/s and 0 L/s flow for expiration and inhalation respectively
were added to the DataPad and manually entered into LabChart as conversion units.
Manometer Calibration-Oral Pressure
Prior to the participant’s arrival, oral pressure offset was zeroed while
digitizing in LabChart by adjusting the knob on the MC-110 amplifier. Resting
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reading from the oral pressure transducer (PTL-1, Glottal Enterprises, Syracuse, NY)
in a room was set to 0 volts as the atmospheric pressure. The GE calibrator unit was
used to input a known pressure into the pressure transducer to complete a 2 point
calibration process in LabChart. The stopper was inserted in the top flow port (used
for pressure calibration tasks) on the GE calibrator unit and the pressure transducer
was inserted into the pressure port. The setting on the GE calibrator was toggled to
pressure. Digitizing in LabChart was initiated and the following pressures were
applied: 0 mmHg, 3 mmHg, 5 mmHg, 7 mmHg, 10 mmHg, 15 mmHg. The pressure
values (in volts) for the 5 mmHg and 15mmHg known pressure values were added
to the DataPad and manually entered into the unit conversion. The millimeters of
mercury (mm Hg) measurement was used in this study.

Figure 2.Manometer calibration. Catheter is inserted into pressure
chamber of the Delta-Cal digital pressure calibrator.
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Manometer Calibration-Pharyngeal Pressure
Prior to the participant’s arrival, the CTO-3 Gaeltec manometer calibration
was a 2 part process. The manometer catheter was connected to the bridge
amplifier. The three pressure sensors, base of tongue, hypopharyngeal and UES,
were zeroed by selecting the zero function under the bridge amp tab in the channel
menu. Each channel was zeroed separately. The digitizing display window
demonstrated the pre-zeroed pressure reading graphically drop to zero. If zero,
then the researcher pressed ‘okay’ to accept. The second step was to determine 2
calibration points for unit conversion from volts into mmHg pressure. Prior to
beginning the calibration process, a battery tester was used to ensure adequate
charge for the digital manometer calibrator. The CTO-3 manometer was placed into
a flexible tubing chamber attached to the Delta-Cal® digital pressure calibrator
(Utah Medical, Midvale, UT) (Figure 2). The collet was tightened after the 3 sensors
were placed deep in the chamber without risk of being damaged. Digitizing in
LabChart was initiated while incremental known pressures were applied within the
sealed tubing chamber connected to the Delta-Cal. The pressures applied included: 0
mmHg (atmospheric pressure), 5 mmHg, 25 mmHg, 50 mmHg, 75 mmHg, 100
mmHg, 125 mmHg, 0 mmHg, -25 mmHg, and -50 mmHg. Based on the experimental
tasks, signal recording values (in volts) were added to the DataPad for 50 mmHg
and 125 mmHg from each of the 3 channels. The conversion values from DataPad
(in volts) are added to LabChart. A linear interpolation in excel of the CTO-3
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manometer sensors using conversion values of ranging -50 mmHg to 125 mmHg
revealed a R2=.999 (Figures 3-5).

Figure 3. Linear relationship during manometer calibration for base of
tongue (BOT). A linear relationship was determined when applying a
known pressure (mmHg) from the pressure calibrator to the BOT sensor in
the manometer transducer.

Figure 4. Linear relationship during manometer calibration for
hypopharynx. A linear relationship was determined when applying a
known pressure (mmHg) from the pressure calibrator to the hypopharynx
sensor in the manometer transducer.
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Figure 5. Linear relationship during manometer calibration for upper
esophageal sphincter (UES). A linear relationship was determined when
applying a known pressure (mmHg) from the pressure calibrator to the UES
sensor in the manometer transducer.

Determination of Rib Cage and Abdominal Ratios
Before converting the RIP signal into volumes, the amplification ratios of the
RC and AB contributions to lung volume was set for each individual in the seated
position (Konno & Mead, 1967). The RC and AB contributing factors were solved for
in the following equation: estimated lung volume (ELV): spirometer= RC(x) + AB(y).
The AB signal factor, “y”, was equal to 1 based on the study population and
experimental tasks. Therefore, the equation was spirometer=RC(x) + AB(1) to
compute the least errored solution for “x”. The three tasks completed to determine
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the calibration factor included tidal volume breathing, swallow-like breathing and
vital capacity. Tidal volume breathing and swallow-like breathing trial files were
exported off-line into a .RespCal MatLab program provided by Dr. Jessica Huber,
Purdue University. The MatLab script applied a pseudoinverse function to compute
a least errored solution for “x”, the RC contribution ratio.
Tasks
Pulmonary Function Testing
The pulmonary function test is the standard for confirming diagnosis of
COPD and staging of severity based on the forced expiratory volume results (Celli,
2004; Mannino, 2002). A bedside spirometer calculated the forced expiratory
volume in 1 second (FEV1)/forced vital capacity (FVC) ratio. Participants took a
deep breath while keeping a lip seal on a new, unused Moe filter (nSpire Health, Inc.;
Longmont, CO) and blew out hard and fast until they had no additional air to expire.
The screening task was completed with three trials in a seated position to match the
experimental task positioning. The Koko Legend (nSpire Health, Inc.; Longmont, CO)
bedside spirometer unit is regularly used in the clinical respiratory environment.
The spirometer computed the FEV1/FVC ratio accounting for participant age,
gender, height, and weight in determining expected values. These values were
entered using the touchscreen before beginning the screening task with the
participant. The KoKo Legend provided printable graphic and table-type output.
Healthy participants exceeded 70% and COPD participants performed at 70% or
below.
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Calibration of the spirometer was completed prior to participant arrival
using an nSpire 3 liter (L) canister. The calibration sequence prompts were
provided on the touchscreen. The Koko Legend’s spirometer head zeros while held
steady in the room without airflow. The 3 L canister was securely fit to an nSpire
Moe filter attached to the spirometer head. The canister plunger was pulled and
plunged based on the time sensitive device prompts. Graph and table calibration
output was printed, reviewed, and included in the participant’s research file.
Other Screening Tasks
Participants completed the Dysphagia Handicap Index (DHI), a valid and
reliable measure of the physical, emotional, and functional impact of swallowing
difficulties on individuals (Silbergleit, Schultz, Jacobson, Beardsley, & Johnson,
2012). Responses to 25 statements were recorded as either always (4 points),
sometimes (2 points) or never (0 points) resulting in a maximum potential score of
100. The nine physical statements related to tangible symptoms such as coughing,
weight loss or utilization of strategies to swallow better. Participant responses to
nine functional statements focused on alterations in lifestyle such as alternative
nutrition, taking longer to eat or altering their diet. The seven emotional statements
addressed the participant’s perception of their response to difficulty swallowing
such as being more fearful, experiencing avoidance, or being embarrassed. DHI
respondents also provided a self-perceived, overall severity of swallowing difficulty.
Overall severity rating ranged 1 (normal) to 7 (severe problem) on an equal interval
scale but was not included in the total score (Silbergleit et al., 2012). A maximum
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score of 8 on the 25 statements is within normal limits (Silbergleit et al., 2012). The
cut-off score on the DHI for healthy participant inclusion was 8. COPD participants
completed the DHI but a requisite score for inclusion was not applied to allow
symptomatic and asymptomatic individuals with COPD to participate.
The MMSE, a widely administered cognitive screening tool, with a max score
of 30, was administered to all participants. A score of 21 points or greater was
required for inclusion in both the healthy and COPD groups. A score between 25 and
30 was normal; the score of 21-24 suggested mild cognitive impairment. This
inclusion level was determined based on the cognitive load necessary to complete
the experimental tasks. Prospective participants completed the Reflux Symptom
Index to determine the symptom severity of reflux. The RSI, a valid and reliable
rating tool, contains 9 self-scored symptom statement items with ordinal ratings
ranging 0 (no problem) to 5 (severe problem). A score >13 is considered abnormal
(Belafsky, Postma, & Koufman, 2002). Reflux may alter the sensory input response
for swallowing. Healthy and COPD participants scored 15 for inclusion in this
study. The higher cut-off score on the RSI for inclusion was set to avoid false
positives of reflux symptoms in the COPD group. Specifically, RSI statements
requiring COPD participants to rate symptoms of excess throat mucous, cough, or
breathing difficulties may relate to their respiratory disease and not be indicative of
reflux symptoms.
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Experimental tasks
Prior to beginning the experimental swallow task, COPD and healthy
participants completed three tasks for individual participant calibration to
determine lung volume when swallowing. These tasks included: two 45 second tidal
volume breathing segments, 5 swallow-like breathing trials, and 5 vital capacity
maneuvers. The participant calibration tasks were completed using respiratory
inductive plethysmography and concurrent spirometry. A nose clip was secured on
the nasal ala, preventing nasal airflow during these tasks. The participant completed
the calibration and experimental tasks in an upright, seated position in a dental
chair. Participants were instructed to “breathe naturally” for the tidal volume task.
Swallow-like breathing instructions were to “imagine you are taking a drink of
water per exhalation but do not swallow” (Hegland, Huber, Pitts, & Sapienza, 2009).
Instructions for the vital capacity maneuver were to “take a deep breath and blow
out hard as much as possible”.
Participants swallowed 20 ml water boluses via medicinal cup across lung
volume conditions for the experimental task. Seven swallow trials at each lung
volume condition were completed. Additional water bolus trials were completed if
real-time signal analysis review verified a trial was not completed at the target lung
volume or insufficient rest breaths occurred before or after the swallow. All
participants completed non-cued, natural swallow trials as the first experimental
task condition to control for carry-over between tasks. The non-cued swallow
condition determined the participant’s usual lung volume for swallowing and
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provided a baseline recording of respiratory-swallow patterning. Three additional
lung volume conditions were completed in a counterbalanced order across
participants: (1) tidal volume (TV, volume at top of quiet inhalation), (2) total lung
capacity (TLC, maximum volume after forced inhalation) and (3) resting expiratory
level (REL, volume at end of quiet exhalation). Participants were instructed to
achieve their target lung volume, insert the bolus into the mouth, and swallow. Each
participant received instruction for the 3 cued lung volume conditions and
demonstrated competence on each condition before beginning experiment task
trials. Competence at lung volume conditions was determined by real-time signal
analysis in LabChart (AD Instruments). Additional instruction on lung volume
conditions was provided when participants were unable to reach a targeted lung
volume condition. Additional bolus trials were added to compensate for discarded
trials.
Participants rated their sensation of shortness of breath on the Modified
Borg Dyspnea Scale before and after lung volume condition tasks using a visual
scale. The Modified Borg Dyspnea Scale is a valid and reliable perceptual rating scale
for disordered populations with COPD and asthma (Kendrick, Baxi, & Smith, 2000).
Participants answered the question “How much difficulty is your breathing causing
you now?” Ordinal scale responses ranged zero to ten with 0=nothing at all to
10=maximal. Individuals responding in the 3 (moderate) to10 (maximal) scale
range were provided a rest break and rescored. Participants responding with a
score of <3 advanced to the next task. Two COPD participants reported changes on
the Modified Borg Dyspnea Scale at a scale score of 3 (moderate) and one reported a
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4 (somewhat severe). All three participant’s dyspnea resolved within one minute to
lower scores of <3 and each received a 3-5 minute break or rested until they
indicated their verbal consent to continue. Participant’s oxygenation levels were
assessed during each event with a score >3 and found within the expected range.
Participants completed baseline and interval blood oxygenation (SpO2%)
screens using a clinical bedside pulse oximeter, the NellCor™ N-20 (Medtronic,
Minneapolis, MN USA). A finger-tip probe was placed on the index finger to
determine the arterial oxygenation saturation percentage, the percent of red blood
cells carrying oxygen. Values of 90-100% SpO2 are considered within acceptable
range; healthy individuals are typically 94-100%. Participants with COPD can have
resting oxygenation levels in the lower 90% range. Rest breaks after exertion
typically return individuals back to their baseline oxygenation levels. One COPD
participant experienced a singular instance of desaturation to <90% SpO2 but
immediately returned to >90% when given a short 3-5 minute rest break. Dyspnea
level rating via the Modified Borg Dyspnea Scale remained <3 participant response
rating during the desaturation.
A 10-point visual analogue scale for fatigue was administered at baseline and
between lung volume condition tasks. A score of zero indicated energetic with no
fatigue. A score of five specified moderate fatigue and a score of 10 was the worst
possible fatigue. A score of three (mild-moderate fatigue) was the threshold to
implement a rest break. Two COPD participants provided a score of 5. Both
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participants were provided a 3-5 minute rest break, reassessed, and able to proceed
with tasks without incident.
Off-Line Computation Methods
Swallows that were not at the intended lung volume condition were excluded
from analysis. Estimation of lung volume was calculated by taking an average of the
end expiratory level (EEL) on a minimum of 3 tidal volume breaths preceding the
experimental swallow trials. The RC and AB values at the time of BOT pressure
increase onset, the marker of pharyngeal swallow onset in the study, were added to
DataPad. A mean of end expiratory level (EEL) in quiet breaths before each swallow
trial was computed and subtracted from each RC and AB value to account for signal
drift. The estimated lung volume (ELV) was calculated for each swallow trial using
the formula: ELV= RC(x) + AB(1). Mean vital capacity was determined from peak to
trough difference in the spirometer signal from the participant’s vital capacity trials.
The ELV was reported in liters while the percent vital capacity (%VC) was computed
by (ELV/VC) *100. The expiratory reserve volume (ERV) was computed and
included in the equation ELV=RC(x) +AB(1) +ERV. End expiratory levels in tidal
breathing prior to each vital capacity (VC) trial were averaged. The difference from
EEL to vital capacity trough was determined using the spirometer signal.
1.7

Results

Power
Pilot data (n=4) of pharyngeal swallowing durations were utilized to determine
effect size based on means and standard deviations (SD). Pilot data sampling
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included 3 healthy participants and 1 COPD. Effect size computation was .27 using
G*Power 3.1.9.2. An ANOVA repeated measures, within-between subject
interactions were run with a Bonferroni correction to =0.017 to account for 3
dependent variable measures. Power was set at .8 yielding a requisite sample size of
26 total participants, 13 in each group (Figure 6a).
Recruitment was slower than expected and the study only resulted in 10 healthy
older adults (7 female, Mage=59.4) and 9 individuals with COPD (3 female, Mage=71.9)
who completed the study. If the effect size was higher, at 0.35, then the power
would remain the same at 0.80 with 9 subjects in each group (Figure 6b).

Figure 6a. Power analysis A. Output
using G*Power 3.1.92. Total sample size
is 26, with an effects size of 0.27

Figure 6b Power analysis B. Output using
G*Power 3.1.92. Total sample size is 18, with
an effects size of 0.35
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Statistical analyses were completed with IBM SPSS Statistics 24.
Statistical analysis methods were determined by a statistical consultant. Participant
group characteristics are provided in Table 6.
Table 6
Characteristics of COPD and Healthy Participants

COPD (n=9)

Healthy (n=10)

Criteria
Age

M=71.99 years

M=59.40years

Range=61-83 years

Range=50-77 years

Gender

3 Female; 6 Male

7 Female; 3 Male

Respiratory

M=51.67% (SD=8.31)

M=82.2% (SD=7.4)

M=52.33% (SD=16.95)

M=101.6% (SD=13.89)

Range= 34%-80%

Range=72%-120%

Function Screening
Ratio (FEV1/FVC)
FEV1 % Predicted

Dysphagia Handicap M=10.44 (SD=7.99)

M=1.80 (SD=2.39)

Index (DHI)

Normal (n=10)

Mild(n=2); Moderate
(n=1); Normal(n=6)

Reflux Symptom

M=7.44 (SD=3.75)

M=2.50 (SD=2.37)

M=27.89(SD=1.45)

M=29.70 (SD=0.48)

Index
Mini Mental State
Examination
(MMSE)
Note. FEV1 % predicted is derived from the participant’s forced expiratory volume in one second
divided by the average FEV1% in the population based on comparable age, gender, height, and
mass. FEV1% predicted values determine COPD severity in conjunction with a requisite
FEV1/FVC <0.7.
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Lung volume estimations
A mixed model ANOVA analysis determined the effects of group (healthy or
COPD) and within subject repeated lung volume conditions (NC, TV, TLC, and REL).
The estimated lung volumes (in liters) during swallowing were significantly lower
in individuals with COPD compared with older healthy, F(1,17)=8.119, p=.011
(Table 7, Figure 7). A statistically significant main effect was found of lung volume
condition on estimated lung volume, F(3,51)=64.82, p=<.001 (Table 9). Pairwise
comparisons of lung volume conditions demonstrated significant differences
between all lung volume conditions (p<.001) except the NC and TV volume
conditions, p=.249. Non-cued lung volume condition means, regardless of group,
were lower than TV condition means (Table 7). The interaction between group and
lung volume condition was not statistically significant, F(3,51)=.871, p=.462.

Figure 7. Boxplots with quartile distributions for ELV across conditions by
group.
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Table 7
Estimated Lung Volume and Percent Vital Capacity Means with Standard Deviations
Condition
COPD (n=9)
Healthy (n=10)
Mean (SD)

%VC(SD)

Mean(SD)

% VC(SD)

NC

1.12(.55)

37.49(13.36)

1.98 (.87)

47.82(17.42)

TV

1.38(.55)

47.74(11.39)

2.25(.83)

54.84(17.62)

TLC

2.22(.95)

76.09(16.75)

3.24(.83)

80.15(16.98)

REL

.687(.41)

23.10(10.68)

.1.30(.58)

32.17(13.89)

Note. Mean is in liters. % Vital Capacity (%VC) is derived from estimated lung
volume mean divided by vital capacity.
Estimated lung volumes were also analyzed as a percent of vital capacity
(%VC), calculated by ELV/VC*100. Mean vital capacity for individuals with COPD in
this study was 2.81L (SD=.93) and healthy averaged 4.08L (SD=.921). Percent vital
capacities for each group were similar across the 4 lung volume tasks (Table 7).
Pharyngeal Durations
The pharyngeal durations were very similar in the two groups (Table 8). Pharyngeal
swallow durations were analyzed by mixed method ANOVA to determine group
differences across volume conditions. Main effects for group (F(1,17)=.903, p=.355)
and by ELV condition (F(3,51)=.311, p=.817) were not significant. An interaction
between individuals with COPD and healthy across volume conditions was also not
significant, F(3,51)=1.70, p=.178. Descriptive means suggest that the pharyngeal
swallow durations in the NC condition tended to be longer in individuals with COPD
than the healthy controls (M=.977s, SD=.31).
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Table 8
Pharyngeal Swallow Durations
Condition
COPD (n=9)

Healthy (n=10)

NC

.977(.31)

.787(.20)

REL

.926(.23)

.807(.26)

TV

.907(.25)

.823(.24)

TLC

.841(.24)

.841(.27)

Note. Mean is in seconds. Parentheses values represent the standard deviations.

Relationships Between Pharyngeal Durations and Estimated Lung Volume
The relationship between lung volume and pharyngeal swallow duration
was analyzed by Pearson’s correlation analysis. In individuals with COPD, there was
a significant inverse correlation between lung volume and the duration of the
pharyngeal swallow, r(34)=-0.506, p=.002 (Figure 8). The estimated lung volume at
the time of the swallow explained 26% of the variation in pharyngeal swallow
duration. In the older healthy participants, no relationships were found between
estimated lung volume and pharyngeal swallow duration r(38)=.099, p=.542 (Figure
9).

42

Figure 8. Scatterplot of ELV and PD relationship in COPD participants
across lung volume conditions.

Figure 9. Scatterplot of ELV and PD relationship in older healthy
participants across lung volume conditions.
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In individuals with COPD, correlation analyses within each lung volume
condition were also computed. In the normal swallows (NC) condition, there was a
significant inverse relationship between ELV and pharyngeal swallow duration,
r(1)=-0.817, p=.007 (Figure 10). Individuals with COPD also tended to have an
inverse relationship with pharyngeal swallow duration in the TLC volume condition,
r(1)=-0.606, p=.085.

Figure 10. Scatterplot of ELV and PD relationship in NC swallow
for individuals with COPD.

In the healthy adults, no relationship between ELV and PD was found within
any of the lung volume conditions for older healthy participants.
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Respiratory-Swallow Patterning
To compute the percent of respiratory cycles that resumed swallowing in the
inspiratory phase, we combined the percent of cycles with an expiratory onset to an
inspiratory swallowing offset with the percent of cycles that had inspiratory onset
to inspiratory off set. Box plots of the percentages in each group of swallowing
offsets in the inspiratory cycle showed that the healthy participant group had some
resumption of swallowing on inspiration in the REL condition.

Figure 11. Boxplots showing quartile distributions for percent of
swallows resumed in inspiration for COPD and healthy individuals.

Within each lung volume condition, we conducted a t-test between groups
with a directional hypothesis that the COPD participants would have a higher
percentage of swallows resume on inspiration than the healthy participants. The
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results are presented in Table 9. In the NC condition, the COPD participants had a
greater percentage of swallows resuming on inspiration than the healthy
participants, t(11)=-1.978, p=0.037.
Table 9
Percent of Swallow Resuming on Inspiration
Condition
COPD (S.D.)
Healthy (S.D.)

T- test (p value)

REL

54.71 (30.7)

32.43 (32.15)

-1.54 (0.071)

NC

31.35 (28.87)

10.54 (13.46)

-1.978 (0.037)

TV

18.851 (32.31)

10.00 (31.623)

-0.602 (0.278)

A one-way repeated measures ANOVA was conducted to determine whether
individuals with COPD had statistically significant differences in resumption of
respiration in inspiration across lung volume conditions. Analyses revealed that
lung volume condition at the time of the swallow results in significant changes in
percent of swallows resumed in inspiration (F(3,24)=7.803, p=.001, partial 
2=.494.).

The percent occurrence for COPD participants resuming respiration on

inspiration after the swallow decreased as lung volumes increased (Figure 11). Post
hoc analysis with a Bonferroni adjustment revealed that the percent of respiration
resumption in inspiration was statistically significantly decreased in TLC compared
with REL (43.59(95% CI, 14.82 to 72.36) %, p=.005) and in TV compared with REL
(35.85(95% CI, 14.37 to 57.34) %, p=.002. Other post hoc comparison groups
including NC swallows with cued swallow lung volume conditions were not
significantly different.
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Discussion

Lung volume at the time of the swallow has been posited to play an
important role in the coordination of breathing and swallowing by altering sensory
feedback from respiration. Pulmonary stretch receptors provide sensory input to
the central pattern generators for respiration which may assist in regulation of the
requisite, coordinated patterning between swallowing and respiration. The pattern
ensures the cessation of respiration during the swallow followed by a resetting in
the preferred expiration phase (Martin-Harris et al., 2003; Martin-Harris, 2008;
Shaker, 1992). This study investigated the effects of lung volume on swallow timing
and respiration resetting patterning in individuals with COPD, in comparison with
healthy participants.
Lung Volume for Swallowing
Based on the study findings, individuals with COPD swallow had significantly
lower lung volumes than their older, healthy peers. Given the COPD disease
characteristics of bronchoconstriction, decreased airflow within the smaller
airways, and thoracic muscle wasting with disease progression (Gatta, Fredi,
Aliprandi, Pini, & Tantucci, 2013), swallowing at a lower lung volume was expected.
Despite the significantly lower lung volume in COPD compared with healthy
individuals, the COPD had similar percent vital capacity values to the healthy
participants. The similarity suggest that both groups used similar proportions of
their vital capacity when breathing even though the COPD participants were
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reduced in their vital capacity compared with the healthy participants, similar to a
previous study (Yuan et al., 2014).
Wheeler-Hegland et al. (2009) posited that there is a lung volume range that
evokes a safe and effective swallow. They found that young healthy swallow at
respiratory volumes between 43% and 64% of their vital capacity. The current
study found that natural, non-cued swallows in older healthy participants and
individuals with COPD swallow occurred at 47.82% and 37.49% of vital capacity,
respectively. The swallows of our older healthy participants were consistent with
the range of normal swallows of between 43%-64% VC of Wheeler-Hegland et al.
(2009), even though our healthy participants (aged 50 to 83) were older than those
of Wheeler-Hegland et al. (2009) (aged 19-28). This age difference may account for
the lower %VC findings in this study. Aging is associated with decreases in vital
capacity due to changes in musculoskeletal function (Lalley, 2013). This raises the
question whether the target %VC for a safe, effective swallow changes with age,
which should be explored further.
On the other hand, individuals with COPD tended to swallow at a slightly
lower %VC than their older healthy peers and potentially may have been further
away from the ideal target %VC. Hyperinflation of the lungs occurs with
progressive severity of COPD and may have played a role in the lower estimated
lung volumes found in the COPD participants this study. Air volume residuals in the
lungs after forceful exhalation in a vital capacity maneuver were not measured in
this study. Possibly, larger lung volume residuals in individuals with COPD leave less
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volume capacity for performing everyday tasks, such as swallowing. The lower
estimated lung volume in swallowing may further support the hypothesis that
persons with COPD may not adequately activate pulmonary stretch receptors or
subglottal pressure receptors for adequate feedback to the respiratory central
pattern generator for coordinating respiration with swallowing.
Swallow Timing and Lung Volume
Lung volume plays a significant role in altering the central neural control
coordination between respiration and swallowing. However, subglottal pressure is
increased when the vocal folds adduct during a swallow. The amount of increase in
subglottal pressure is driven by lung volume paired with expiratory recoil forces
(Gross, Carrau, Slivka, Gasser, Smith,..Sciurba, 2012). Although we did not measure
subglottal pressure in this study, it may have been reduced by reduced changes in
volume for swallowing in the COPD subjects. Afferent pulmonary stretch receptors
may also have inputs to the central pattern generator for swallowing control to
modulate the swallow motor sequence (Jean, 2001). Possibly, a reduction in
subglottal pressure change due to reduced change in pulmonary volume may have
played a role in the pathophysiology of swallowing control in the COPD participants
in this study and should be explored further. Swallowing at a low volume near
residuals in healthy participants yielded a significantly slower swallow pattern than
swallowing at the top of inspiratory reserve volume (Gross et al., 2003).
Cassiani et al., (2015) found pharyngeal swallow durations of COPD patients
were longer than those of healthy participants. Increased duration in pharyngeal
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swallow has been posited as a compensatory mechanism to allow longer time
periods for bolus movement through the pharynx (Mokhlesi et al., 2002; Chaves et
al., 2014). We did not find increased pharyngeal durations in COPD in this study,
however, we did find a strong inverse relationship between pharyngeal duration
and estimated lung volume in individuals with COPD. The COPD participants had
longer pharyngeal durations at lower lung volumes. This relationship was strongest
in the non-cued swallowing condition in the COPD participants when they had
pharyngeal durations of .98s and were using 1.12L or 37.49% VC, which is below
the requisite volume for swallowing established in previous research. Others have
found longer swallow durations result in increased respiratory rates in individuals
with COPD (Shaker et al., 1992). It is unclear whether the prolonged pharyngeal
durations at low lung volumes for swallowing in the COPD participants were the
result of either a compensatory strategy developed by the patients when at low lung
volumes or a reflexive response to increase respiratory rate due to air hunger. If it
were a reflexive response then prolonged pharyngeal durations would result in an
increase in respiratory rate, which was not evaluated here. However, the increased
incidence of resuming respiration on inspiration after a swallow in the COPD
participants in the low volume conditions suggest that increased respiratory rate
due to air hunger may have played a role.
Respiratory-Swallow Patterning
This study also examined the respiratory-swallow patterning across lung
volume conditions in COPD. Studies demonstrate that healthy individuals typically
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swallow in an expiratory-swallow-expiratory pattern (Cedborg et al., 2010; MartinHarris et al., 2005; Martin-Harris et al., 2003; Shaker et al., 1992; Wheeler Hegland,
et al., 2009). Alterations in the respiratory-swallow pattern can result in increased
risk of aspiration. Multiple studies determined that COPD respiratory-swallow
patterning deviates from the preferred initiation and resumption of respiration in
expiration (Cedborg et al., 2010; Martin-Harris et al., 2005; Martin-Harris et al.,
2003; Shaker et al., 1992; Wheeler Hegland et al., 2009). Similar to previous studies,
individuals with COPD in this study tended to resume respiration in inspiration
more than their older healthy peers. Importantly, COPD restarted respiration after a
swallow less often in inspiration at the higher lung volumes, TLC and TV. COPD
participants swallowing at REL were significantly more likely to resume respiration
on inhalation than when they were swallowing in the TLC or TV.
Summary
The study provided new evidence that individuals with COPD swallow at
lower lung volumes than their healthy, older peers. Further, individuals with COPD
demonstrated an inverse relationship between pharyngeal swallow duration and
the lung volume at the time of the swallow which was not evidenced in the older
healthy participants. Pharyngeal swallow duration was longer at the lower lung
volumes in individuals with COPD. This relationship should be investigated further
to determine whether longer or shorter pharyngeal swallow duration impacts the
safety of the swallow in COPD.
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This study found that individuals with COPD resume respiration in
inspiration significantly more often in their natural swallowing in the non-cued
condition, placing them potentially at greater risk for aspiration, compared with
their older healthy peers. This finding supports previous studies (Cedborg et al.,
2010; Martin-Harris et al., 2005; Martin-Harris et al., 2003; Shaker et al., 1992; Wheeler
Hegland, et al., 2009). Importantly, we determined that increasing lung volume at the

time of the swallow can alter the respiratory-swallow pattern into resumption of
breathing in exhalation at the time of the swallow in individuals with COPD. Future
research would be beneficial in determining if swallowing at a higher lung volume
also reduces incidence of aspiration and could be used as an intervention in patients
with COPD.
Future studies with a focus on improving respiratory function such as airflow
exchange and recoil forces should determine if altering respiratory function results
in improved swallowing outcomes, reduces incidents of COPD exacerbations, and
improves quality of life for individuals with COPD. Studies should examine whether
respiratory muscle strength training can improve swallowing in COPD. Resistive
respiratory training exercises, such as Inspiratory Muscle Strength Training (IMST),
improve inspiratory muscle strength in individuals with COPD (Geddes et al., 2008;
Geddes et al., 2005) and could increase inspiratory volume prior to the swallow.
Expiratory Muscle Strength Training (EMST) improves hyolaryngeal timing and
movement for swallowing in patients with Parkinson Disease (Troche et al., 2010).
EMST also improves expiratory force for a productive cough through active
expiration in disordered populations such as COPD (Laciuga, Rosenbeck, Davenport,
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& Sapienza, 2014). The effects of IMST and EMST in individuals with COPD to
improve lung volume at the time of the swallow may offer benefits for improving
swallow physiology, increasing airway safety and enhancing their quality of life.
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Potential Limitations

Small sample size limits ability to generalize the findings and may have
impacted the statistical analyses. In the pilot testing, we found that the effect size
was 0.27, and the power analysis indicated that 26 participants would be needed in
each group. We were only able to recruit 10 in the healthy group and 9 in the COPD
group. The effect sizes that the results yielded, however, were higher in this study.
For estimated lung volume, the mean of the Cohen’s d effect sizes across the four
lung volume conditions based on the data in Table 7, averaged 1.07, while the mean
Cohen’s d effect sizes for the 3 conditions in percent swallows finishing on
inspiration in Table 9 averaged 0.83. Thus, both were strong effect sizes much
higher than the pilot testing results. The power of the study based on these effect
sizes was ≥0.99.
Recruitment of participants in this study exceeded one year and may be
attributed to conducting the study in a rural hospital. The limited sampling pool
impacted abilities to effectively stratify participants for the study. This resulted in
gender inequality between groups. The COPD group gender composition of men
(n=6) compared with women (n=3) may be skewed based on recent trends of more
women than men being diagnosed (American Lung Association, 2013). Additional
participant sampling should be completed to address the sample inequalities.
COPD participant exclusion criteria excluded individuals with the most
severe COPD, FEV1<30%, and individuals on continuous oxygen from participating
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in the study. Study participants were predominately in the moderate (n=3) to
severe (n=5) COPD severity stage. This study did not include equal representation
from the mild severity (n=1) nor the most severe. Importantly, the most severe
COPD are the individuals most commonly referred for swallowing assessment.
Disease progression and increased frequency of exacerbations is related to
increased aspiration risk (Terada, 2011). Conversely, mild COPD and the emergence
of dysphagia symptoms is less understood. Additional larger studies need to be
completed to include the range of COPD severity in sampling to elucidate the
emergence and progression of dysphagia in individuals with COPD.
COPD participants were included in the study regardless of reported
symptoms of swallowing impairment to ensure inclusion of subclinical dysphagia in
COPD participants. Three participants scored outside the normal range on the DHI.
Only one of the participants who scored a moderate severity on the DHI, was
diagnosed with dysphagia. Two other COPD participants scored in the mild severity
range on the DHI. The remaining 6 COPD participants reported no handicapping
effects on their swallowing.
This study did not include videofluoroscopic assessment of swallowing to
correlate the timing and volume measures with swallow physiology. Future studies
should include a greater spread of individuals with COPD expressing self-perceived
swallow symptoms and inclusion of videofluoroscopy. In clinical practice,
individuals with COPD often underreport symptoms of dysphagia that are later
confirmed in videofluoroscopy swallow examinations. This is hypothesized to result
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from COPD attributing their swallowing symptoms, such as cough, throat clearing,
or increased secretions, to their respiratory disorder.
This study examined individuals in the stable state of the disease process.
Exacerbations of COPD result in reduced pulmonary function and increased risk of
aspiration. Abnormal swallowing examination results occur in increased
frequencies during COPD exacerbations as there is a strong relationship between
swallowing dysfunction and exacerbations in COPD (Terada et al., 2010).
Exacerbation symptoms such as increased phlegm production, significant shortness
of breath, and increased respiratory drive are posited to result in increased
discoordination between respiration and swallowing. However, research has largely
examined individuals with COPD in the stable state. Future research should focus on
determining effects of exacerbated state on swallow function and safety in
individuals with COPD.
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Conclusions

Lung volumes in individuals with COPD were reduced during the swallow and may
contribute to other swallow physiology dysfunction. Individuals with COPD
demonstrate higher pharyngeal swallow durations when swallowing at lower lung
volumes. This relationship between estimated lung volume and pharyngeal swallow
duration was not present in the older healthy. COPD individuals were found to
resume respiration in inspiration post-swallow significantly more often than
healthy. Further, increasing lung volume at the time of the swallow in individuals
with COPD resulted in a significant reduction of respiration resumption in the
inspiratory phase post-swallow. Resuming respiration in the expiratory phase may
decrease risk of aspiration. Additional research investigating lung volume effects on
swallow physiology and functional outcomes is needed to develop efficacious
treatments for dysphagia in individuals with COPD.
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